Waycross Partners, LLC Zoetis Inc. Transaction History

Waycross Partners, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$151.44 - $200.09 $726,912 - $960,432	-4,800 Reduced 32.43%	10,000 $1.97 Million
Q2 2023 Jul 26, 2023	SELL	$160.94 - $186.23 $4,989 - $5,773	-31 Reduced 0.21%	14,800 $2.55 Million
Q1 2023 May 04, 2023	BUY	$145.48 - $175.02 $2.16 Million - $2.6 Million	14,831 New	14,831 $2.47 Million

1,957

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Waycross Partners, LLC with notifications on news.